<SEC-DOCUMENT>0001213900-19-009859-index.html : 20190531
<SEC-HEADER>0001213900-19-009859.hdr.sgml : 20190531
<ACCEPTANCE-DATETIME>20190531121757
ACCESSION NUMBER:		0001213900-19-009859
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20190531
DATE AS OF CHANGE:		20190531

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Enlivex Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001596812
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88278
		FILM NUMBER:		19869416

	BUSINESS ADDRESS:	
		STREET 1:		37 DEREH MENACHEM BEGIN ST.
		STREET 2:		15TH FLOOR
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6522042
		BUSINESS PHONE:		972 (0) 3 7326616

	MAIL ADDRESS:	
		STREET 1:		37 DEREH MENACHEM BEGIN ST.
		STREET 2:		15TH FLOOR
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6522042

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Bioblast Pharma Ltd.
		DATE OF NAME CHANGE:	20160919

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIO BLAST PHARMA LTD.
		DATE OF NAME CHANGE:	20140113

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVIK SHAI A
		CENTRAL INDEX KEY:			0001401412

	FILING VALUES:
		FORM TYPE:		SC 13D

	MAIL ADDRESS:	
		STREET 1:		30 ANMI NAAMIN STREET
		CITY:			RAMAT HASHARON
		STATE:			L3
		ZIP:			47212
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>sc13d0519novik_enlivextherap.htm
<DESCRIPTION>SCHEDULE 13D
<TEXT>
Document 1 - file: sc13d0519novik_enlivextherap.htm

</DOCUMENT>
</SEC-DOCUMENT>